GuanfacineExtended-Release (Par Pharmaceutical Inc.)
Welcome to the PulseAid listing for the Guanfacine drug offered from Par Pharmaceutical Inc.. This Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Par Pharmaceutical Inc. |
NON-PROPRIETARY NAME: | Guanfacine |
SUBSTANCE NAME: | GUANFACINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, EXTENDED RELEASE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2015-06-02 |
END MARKETING DATE: | 0000-00-00 |
Guanfacine Extended-Release HUMAN PRESCRIPTION DRUG Details:
Item Description | Guanfacine Extended-Release from Par Pharmaceutical Inc. |
LABELER NAME: | Par Pharmaceutical Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 1(mg/1) |
START MARKETING DATE: | 2015-06-02 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 10370-533_5fcbfd8e-5260-4c28-b870-f2bf18ed13d5 |
PRODUCT NDC: | 10370-533 |
APPLICATION NUMBER: | ANDA201408 |
Other GUANFACINE Pharmaceutical Manufacturers / Labelers: